Upadacitinib monotherapy is effective for patients with moderate-to-severe atopic dermatitis
1. The proportion of patients with EASI ≥75% was significantly greater in the upadacitinib 30 mg and 15 mg groups ...
1. The proportion of patients with EASI ≥75% was significantly greater in the upadacitinib 30 mg and 15 mg groups ...
1. Individuals diagnosed with atopic dermatitis (AD) as children were at elevated risk of not attaining lower and upper secondary ...
1. In this study, nemolizumab with topical agents and oral antihistamines when compared to topical agents and oral antihistamines alone ...
1. In this study, nemolizumab with topical agents and oral antihistamines when compared to topical agents and oral antihistamines alone ...
1. Commonly prescribed antibiotics in infancy are associated with later diagnosis of allergic disease in childhood Evidence Rating Level: 2 ...
1. In treatment-resistant childhood atopic dermatitis, omalizumab significantly reduced the severity of dermatitis and improved quality of life compared to ...
Atopic dermatitis, a common disorder in the pediatric population, is associated with pruritus that is often worse at night and, ...
Veverimer Versus Placebo in Patients with Metabolic Acidosis Associated with Chronic Kidney Disease: a Multicenter, Randomized, Double-Blind, Controlled, Phase 3 ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.